Inactive Instrument

Sector Chart Nexus BioPharma, Inc.

Equities

NEXS

US65341U1043

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
124B
111B
23.17B -
22.94B -
17.42B